Haptoglobin: Basic and clinical aspects

  • Andrew P. Levy
  • , Rabea Asleh
  • , Shany Blum
  • , Nina S. Levy
  • , Rachel Miller-Lotan
  • , Shiri Kalet-Litman
  • , Yefim Anbinder
  • , Orit Lache
  • , Farid M. Nakhoul
  • , Roy Asaf
  • , Dan Farbstein
  • , Mordechai Pollak
  • , Yitzhak Z. Soloveichik
  • , Merav Strauss
  • , Jonia Alshiek
  • , Alina Livshits
  • , Avery Schwartz
  • , Hoda Awad
  • , Kheir Jad
  • , Hagit Goldenstein

Research output: Contribution to journalReview articlepeer-review

244 Scopus citations

Abstract

Haptoglobin is an abundant hemoglobin-binding protein present in the plasma. The function of haptoglobin is primarily to determine the fate of hemoglobin released from red blood cells after either intravascular or extravascular hemolysis. There are two common alleles at the Hp genetic locus denoted 1 and 2. There are functional differences between the Hp 1 and Hp 2 protein products in protecting against hemoglobin-driven oxidative stress that appear to have important clinical significance. In particular, individuals with the Hp 2-2 genotype and diabetes mellitus appear to be at significantly higher risk of microvascular and macrovascular complications. A pharmacogenomic strategy of administering high dose antioxidants specifically to Hp 2-2 DM individuals may be clinically effective.

Original languageEnglish
Pages (from-to)293-304
Number of pages12
JournalAntioxidants and Redox Signaling
Volume12
Issue number2
DOIs
StatePublished - Feb 2010
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Haptoglobin: Basic and clinical aspects'. Together they form a unique fingerprint.

Cite this